English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Cohen et al. (1) are to be commended for their observational study of 30 patients with longstanding diabetes and BMI 30–35 kg/m2 who were followed for 6 years after laparoscopic Roux-en-Y gastric bypass (LRYGB). The study appropriately challenges using threshold levels to determine indications for treatment based on a continuous variable, BMI (size), which in itself is not a measure of any disease (unlike blood pressure, fasting plasma glucose, or triglycerides).Several items require clarification:1. National Institutes of Health Consensus Development Conferences such as the Gastrointestinal Surgery for Severe Obesity conference in 1991 do not “bound” or “set limits” for treatments: they provide recommendations based on presented evidence. However, third- …

Comment on: Cohen et al. Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild Obesity. Diabetes Care 2012;35:1420–1428